| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.13 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |